130 related articles for article (PubMed ID: 33838964)
1. Immunohistochemical expression levels of cyclin D1 and CREPT reflect the course and prognosis in oral precancerous lesions and squamous cell carcinoma.
Siril YJ; Kouketsu A; Saito H; Takahashi T; Kumamoto H
Int J Oral Maxillofac Surg; 2022 Jan; 51(1):27-32. PubMed ID: 33838964
[TBL] [Abstract][Full Text] [Related]
2. Knocking-down of CREPT prohibits the progression of oral squamous cell carcinoma and suppresses cyclin D1 and c-Myc expression.
Ma J; Ren Y; Zhang L; Kong X; Wang T; Shi Y; Bu R
PLoS One; 2017; 12(4):e0174309. PubMed ID: 28369091
[TBL] [Abstract][Full Text] [Related]
3. [Expressions of FHIT and cyclin D1/CDK4 in oral cancer and oral precancerous lesions].
Yin C; Shen LJ; Xie SM; Ruan P; Yao X
Di Yi Jun Yi Da Xue Xue Bao; 2005 Jul; 25(7):812-4. PubMed ID: 16027075
[TBL] [Abstract][Full Text] [Related]
4. Expression of cyclin D1 correlates with p27
Guan G; Bakr MM; Firth N; Love RM
Oral Surg Oral Med Oral Pathol Oral Radiol; 2018 Aug; 126(2):174-183. PubMed ID: 29550080
[TBL] [Abstract][Full Text] [Related]
5. Cyclin D1 expression and its possible regulation in chewing tobacco mediated oral squamous cell carcinoma progression.
Mishra R; Das BR
Arch Oral Biol; 2009 Oct; 54(10):917-23. PubMed ID: 19679297
[TBL] [Abstract][Full Text] [Related]
6. Cyclin D1 expression in oral squamous cell carcinoma and verrucous carcinoma: correlation with histological differentiation.
Angadi PV; Krishnapillai R
Oral Surg Oral Med Oral Pathol Oral Radiol Endod; 2007 Mar; 103(3):e30-5. PubMed ID: 17197212
[TBL] [Abstract][Full Text] [Related]
7. Daxx and TCF4 interaction links to oral squamous cell carcinoma growth by promoting cell cycle progression via induction of cyclin D1 expression.
Lin GJ; Huang YS; Lin CK; Huang SH; Shih HM; Sytwu HK; Chen YW
Clin Oral Investig; 2016 Apr; 20(3):533-40. PubMed ID: 26205068
[TBL] [Abstract][Full Text] [Related]
8. Immunohistochemical assessment of growth factor signaling molecules: MAPK, Akt, and STAT3 pathways in oral epithelial precursor lesions and squamous cell carcinoma.
Tashiro K; Oikawa M; Miki Y; Takahashi T; Kumamoto H
Odontology; 2020 Jan; 108(1):91-101. PubMed ID: 31062130
[TBL] [Abstract][Full Text] [Related]
9. Immunohistochemical Expression Of Cyclind1 In Conventional Squamous Cell Carcinomaof Oral Cavity.
Rauf M; Azmat H; Shahab S; Ahmad A; Khadija S; Firidi J
J Ayub Med Coll Abbottabad; 2023; 35(1):11-16. PubMed ID: 36849369
[TBL] [Abstract][Full Text] [Related]
10. [Expression and its significance of Cyclin D1 in oral squamous cell carcinoma].
Xing JS; Shi PR; Chen XJ; He DN; Li LH; Nan XR
Hua Xi Kou Qiang Yi Xue Za Zhi; 2011 Jun; 29(3):299-301, 305. PubMed ID: 21776860
[TBL] [Abstract][Full Text] [Related]
11. Immunohistochemical Expression of Cyclin D1 and Ki-67 in Primary and Metastatic Oral Squamous Cell Carcinoma.
Nazar M; Naz I; Mahmood MK; Hashmi SN
Asian Pac J Cancer Prev; 2020 Jan; 21(1):37-41. PubMed ID: 31983161
[TBL] [Abstract][Full Text] [Related]
12. Alterations of rb pathway components are frequent events in patients with oral epithelial dysplasia and predict clinical outcome in patients with squamous cell carcinoma.
Soni S; Kaur J; Kumar A; Chakravarti N; Mathur M; Bahadur S; Shukla NK; Deo SV; Ralhan R
Oncology; 2005; 68(4-6):314-25. PubMed ID: 16020958
[TBL] [Abstract][Full Text] [Related]
13. Expression of immunoregulatory molecules PD-L1 and PD-1 in oral cancer and precancerous lesions: A cohort study of Japanese patients.
Kouketsu A; Sato I; Oikawa M; Shimizu Y; Saito H; Takahashi T; Kumamoto H
J Craniomaxillofac Surg; 2019 Jan; 47(1):33-40. PubMed ID: 30466788
[TBL] [Abstract][Full Text] [Related]
14. [Expression of tumor suppressor gene PTEN, PIP3 and cyclin D1 in oral squamous cell carcinoma and their correlations].
Xie SM; Shen LJ; Yin C; Ruan P; Yao X
Zhonghua Kou Qiang Yi Xue Za Zhi; 2006 Jul; 41(7):407-10. PubMed ID: 17067457
[TBL] [Abstract][Full Text] [Related]
15. Cyclin d1 expression and its correlation with histopathological differentiation in oral squamous cell carcinoma.
Saawarn S; Astekar M; Saawarn N; Dhakar N; Gomateshwar Sagari S
ScientificWorldJournal; 2012; 2012():978327. PubMed ID: 22629227
[TBL] [Abstract][Full Text] [Related]
16. [Expressions of PTEN and FHIT in oral squamous cell carcinoma and their relations with cyclin D1].
Shen LJ; Xie SM; Yin C; Ruan P; Yao X
Di Yi Jun Yi Da Xue Xue Bao; 2005 Jan; 25(1):79-82. PubMed ID: 15684005
[TBL] [Abstract][Full Text] [Related]
17. Correlation of cyclin D1 expression with aggressive DNA pattern in patients with tobacco-related intraoral squamous cell carcinoma.
Das SN; Khare P; Singh MK; Sharma SC
Indian J Med Res; 2011 Apr; 133(4):381-6. PubMed ID: 21537090
[TBL] [Abstract][Full Text] [Related]
18. Immunohistochemical assessment of Eph/ephrin expression in oral squamous cell carcinoma and precursor lesions.
Saito H; Oikawa M; Kouketsu A; Takahashi T; Kumamoto H
Odontology; 2020 Apr; 108(2):166-173. PubMed ID: 31654153
[TBL] [Abstract][Full Text] [Related]
19. MicroRNA-501-3p restricts prostate cancer growth through regulating cell cycle-related and expression-elevated protein in tumor/cyclin D1 signaling.
Zhang Z; Shao L; Wang Y; Luo X
Biochem Biophys Res Commun; 2019 Feb; 509(3):746-752. PubMed ID: 30621914
[TBL] [Abstract][Full Text] [Related]
20. Integrative analysis of gene alterations and immunoexpression profiles of cell cycle checkpoints in oral squamous cell carcinoma.
Pérez-Sayáns M; Chamorro-Petronacci CM; Lorenzo-Pouso AI; Peñaranda JMS; López-López J; Blanco-Carrión A; García-García A
Cancer Biomark; 2020; 27(1):95-103. PubMed ID: 31683463
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
